These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8515424)

  • 21. Manoalide.
    Soriente A; De Rosa MM; Scettri A; Sodano G; Terencio MC; Payá M; Alcaraz MJ
    Curr Med Chem; 1999 May; 6(5):415-31. PubMed ID: 10101221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the interfacial binding surface of human secretory group IIa phospholipase A2.
    Snitko Y; Koduri RS; Han SK; Othman R; Baker SF; Molini BJ; Wilton DC; Gelb MH; Cho W
    Biochemistry; 1997 Nov; 36(47):14325-33. PubMed ID: 9398150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bee venom phospholipase A2 is recognized by the macrophage mannose receptor.
    Mukhopadhyay A; Stahl P
    Arch Biochem Biophys; 1995 Dec; 324(1):78-84. PubMed ID: 7503563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of a consensus recognition site for phosphatidylcholine separate from the active site in cobra venom phospholipases A2.
    Ortiz AR; Pisabarro MT; Gallego J; Gago F
    Biochemistry; 1992 Mar; 31(11):2887-96. PubMed ID: 1550815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of surface hydrophobic residues in the interfacial catalysis of bovine pancreatic phospholipase A2.
    Lee BI; Yoon ET; Cho W
    Biochemistry; 1996 Apr; 35(13):4231-40. PubMed ID: 8672459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
    Randazzo A; Debitus C; Minale L; García Pastor P; Alcaraz MJ; Payá M; Gomez-Paloma L
    J Nat Prod; 1998 May; 61(5):571-5. PubMed ID: 9599251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2.
    Dudler T; Chen WQ; Wang S; Schneider T; Annand RR; Dempcy RO; Crameri R; Gmachl M; Suter M; Gelb MH
    Biochim Biophys Acta; 1992 Dec; 1165(2):201-10. PubMed ID: 1450215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational changes associated with activation of bee venom phospholipase A2.
    Ahmed T; Kelly SM; Lawrence AJ; Mezna M; Price NC
    J Biochem; 1996 Dec; 120(6):1224-31. PubMed ID: 9010774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural elements of ligand recognition site in secretory phospho-lipase A2 and structure-based design of specific inhibitors.
    Singh N; Somvanshi RK; Sharma S; Dey S; Kaur P; Singh TP
    Curr Top Med Chem; 2007; 7(8):757-64. PubMed ID: 17456039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue.
    Scott DL; Otwinowski Z; Gelb MH; Sigler PB
    Science; 1990 Dec; 250(4987):1563-6. PubMed ID: 2274788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human secretory class II phospholipase A2 by heparin.
    Dua R; Cho W
    Eur J Biochem; 1994 Apr; 221(1):481-90. PubMed ID: 8168536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PLA2 inhibitory activity of marine sesterterpenoids cladocorans, their diastereomers and analogues.
    Miyaoka H; Yamanishi M; Mitome H
    Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):268-70. PubMed ID: 16462082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of an imperfect neutral diluent and outer vesicle layer scooting mode hydrolysis to analyze the interfacial kinetics, inhibition, and substrate preferences of bee venom phospholipase A2.
    Yu BZ; Ghomashchi F; Cajal Y; Annand RR; Berg OG; Gelb MH; Jain MK
    Biochemistry; 1997 Apr; 36(13):3870-81. PubMed ID: 9092817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipase A2 engineering. Deletion of the C-terminus segment changes substrate specificity and uncouples calcium and substrate binding at the zwitterionic interface.
    Huang B; Yu BZ; Rogers J; Byeon IJ; Sekar K; Chen X; Sundaralingam M; Tsai MD; Jain MK
    Biochemistry; 1996 Sep; 35(37):12164-74. PubMed ID: 8810924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipase A2 engineering. X-ray structural and functional evidence for the interaction of lysine-56 with substrates.
    Noel JP; Bingman CA; Deng TL; Dupureur CM; Hamilton KJ; Jiang RT; Kwak JG; Sekharudu C; Sundaralingam M; Tsai MD
    Biochemistry; 1991 Dec; 30(51):11801-11. PubMed ID: 1751497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural analysis of early toxic effects produced by bee venom phospholipase A2 and melittin in Sertoli cells in rats.
    Tilinca M; Florea A
    Toxicon; 2018 Jan; 141():94-103. PubMed ID: 29229236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of structural elements of bee venom phospholipase A2 involved in N-type receptor binding and neurotoxicity.
    Nicolas JP; Lin Y; Lambeau G; Ghomashchi F; Lazdunski M; Gelb MH
    J Biol Chem; 1997 Mar; 272(11):7173-81. PubMed ID: 9054413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of bee venom phospholipase A2 through a peptide-enzyme complex.
    Mingarro I; Pérez-Payá E; Pinilla C; Appel JR; Houghten RA; Blondelle SE
    FEBS Lett; 1995 Sep; 372(1):131-4. PubMed ID: 7556634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
    Mori A; Thomas P; Tagaya Y; Iijima H; Grey H; Ishizaka K
    Int Immunol; 1993 Aug; 5(8):833-42. PubMed ID: 7691164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue.
    White SP; Scott DL; Otwinowski Z; Gelb MH; Sigler PB
    Science; 1990 Dec; 250(4987):1560-3. PubMed ID: 2274787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.